What GLP-1s actually cost, and who ends up covering it
List prices sit around $1,000–$1,350 a month for every brand-name GLP-1. Almost nobody pays that. Here's why, and what determines what you'll actually owe.
What each drug costs without insurance
| Drug | Active ingredient | List price (28-day supply) |
|---|---|---|
| Ozempic | Semaglutide | ~$935/mo |
| Wegovy | Semaglutide | ~$1,350/mo |
| Mounjaro | Tirzepatide | ~$1,080–1,112/mo |
| Zepbound (pens) | Tirzepatide | ~$1,086/mo |
| Zepbound (vials, cash-pay) | Tirzepatide | $349–499/mo |
List price is what the manufacturer charges before any discount, insurance, or savings program is applied — almost nobody actually pays it. It changes often; treat these as a starting reference, not a quote.
Whether your plan covers it depends on the diagnosis
Diabetes indication (Ozempic, Mounjaro)
- Commercial insurance coverage is comparatively common when there's a documented type 2 diabetes diagnosis
- Typical copay with coverage: $25–$100/month
- Medicare Part D generally covers these for diabetes
Weight-loss indication (Wegovy, Zepbound)
- Coverage is inconsistent — only a minority of large employer plans covered weight-loss GLP-1s as of 2025
- Almost always requires prior authorization: documented BMI, prior weight-loss attempts, and comorbidities
- Standard Medicare Part D can't cover a drug for weight loss alone, though Wegovy can be covered for cardiovascular risk reduction in eligible patients
What actually slows this down
Most commercial plans take roughly 5–15 business days to decide a prior authorization for a weight-loss GLP-1, though it can range from about 48 hours to over a month depending on the insurer. The single most common cause of delay isn't the insurer — it's an incomplete submission. Missing BMI documentation, prior weight-loss attempt records, or comorbidity confirmation restarts the review clock. A clinical team that submits a complete package the first time is the fastest path through.
Manufacturer programs almost always beat pharmacy price
Novo Nordisk (Ozempic, Wegovy)
- Commercially insured patients with coverage: as low as $25/fill with a savings card
- Uninsured, cash-pay: Wegovy oral tablets available from NovoCare starting around $149/month for the starter dose
- A subscription program for Wegovy through select telehealth providers began rolling out in March 2026
Eli Lilly (Mounjaro, Zepbound)
- Commercially insured patients with coverage: savings card can bring Zepbound to as little as $25/fill
- Uninsured, cash-pay: LillyDirect Self Pay sells Zepbound vials starting around $349–499/month, well under the pen list price
- Mounjaro has no comparable direct cash-pay vial program — if cost is the deciding factor and weight loss is your goal, Zepbound is usually the cheaper path to the same active ingredient
Medicare GLP-1 Bridge program: starting July 1, 2026 through December 31, 2027, eligible Medicare Part D beneficiaries can access certain weight-loss GLP-1s — including Wegovy and Zepbound — for a flat $50/month through this temporary pilot. Eligibility rules apply; confirm current status with Medicare or your plan before assuming you qualify.
Common questions
Why is Wegovy more expensive than Ozempic if they're the same drug?
Pricing reflects the approved indication and market positioning, not the manufacturing cost of the drug itself. Wegovy is priced and marketed specifically as a weight-management treatment, which commands a different price point than a diabetes drug — even though both are semaglutide.
What if my insurance denies the prior authorization?
Denials can be appealed, and overturn rates for GLP-1 obesity medications have improved as clinical evidence has strengthened. An appeal typically needs more complete documentation than the original request — updated BMI records, a clearer comorbidity case, or evidence of prior weight-loss attempts. Your prescriber's office usually manages this process.
Are compounded GLP-1s a cheaper legitimate option?
Compounded semaglutide and tirzepatide have been available at lower cash prices through 503A and 503B pharmacies, but they are not FDA-approved finished products, and regulatory treatment has been tightening — the FDA proposed excluding these drugs from the 503B bulk list in April 2026. Quality and sourcing vary by pharmacy. This is a decision to make with a licensed provider, not on price alone.
Does telehealth pricing include the medication?
Not always — this is the most common source of sticker shock. Many telehealth providers separate a membership or visit fee from the medication cost, and headline pricing sometimes only reflects one of the two. Always ask for the full monthly total, medication included, before enrolling. See our provider comparison for specifics.
Compare telehealth providers
Ro, Found, and Sequence structure their pricing differently — some bundle medication into a membership fee, some don't. See how the total cost actually breaks down.
Medical disclaimer: This page is for general information and isn't a substitute for professional medical or financial advice from your insurer. Talk to a licensed healthcare provider and your insurance plan directly before making treatment decisions based on cost.
Advertising disclosure: DosageBuzz has affiliate partnerships with some telehealth providers linked on this page. We may earn a commission if you sign up through these links, at no additional cost to you.